Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Phosphodiesterase 3 Inhibitor [EPC]

Known as: Phosphodiesterase 3 Inhibitor, Phosphodiesterase III Inhibitor 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
OBJECTIVE Atrial fibrillation (AF) represents the most common arrhythmia encountered in cardiology department. The purpose of… Expand
Is this relevant?
2019
2019
BACKGROUND Cilostazol, a phosphodiesterase 3 inhibitor (PDE3I), is a platelet aggregation inhibitor and vasodilator that is… Expand
Is this relevant?
2019
2019
Despite the availability of effective antiulcer medications, their suboptimal safety profile ignites the search for alternative… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
Phosphodiesterase 3 inhibitors have been used successfully in pediatric patients with acute or chronic myocardial dysfunction… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2015
Review
2015
OBJECTIVE: To assess the efficacy and safety of cilostazol on the progression and regression of symptomatic intracranial artery… Expand
  • figure 4
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2014
2014
OBJECTIVE To investigate whether bladder dysfunction after bladder outlet obstruction (BOO) could be altered by treatment with… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
MOTS CLÉS Association d’antiagrégants plaquettaires ; Maladie thrombotique More than 22 million Americans are estimated to take… Expand
  • table 1
Is this relevant?
2008
2008
BACKGROUND Cilostazol, a phosphodiesterase 3 inhibitor, is an antiplatelet drug that is widely used for preventing cardiovascular… Expand
Is this relevant?
1999
1999
The effect of topical administration of phosphodiesterase (PDE) 3 inhibitors on the airway is not clear. In order to examine the… Expand
Is this relevant?
1996
1996
1. This study was designed to investigate the role of rat phosphodiesterase 3 (RPDE3) in regulation of liver metabolism in sepsis… Expand
Is this relevant?